OBJECTIVES: Previous studies have shown that patients who undergo oesophageal cancer surgery in high-volume hospitals have lower postoperative mortality rates. However, the impact of hospital volume on long-term survival is controversial.
INTRODUCTION
Surgery is the main curative treatment for oesophageal cancer. However, despite recent improvements in minimally invasive surgical techniques and perioperative care, oesophagectomies are associated with high morbidity and mortality rates. Since oesophagectomies are high-risk, low-volume procedures, patients who are treated by more experienced surgeons in high-volume hospitals may have better outcomes than those who are treated by less experienced surgeons in low-volume hospitals. Many populationbased studies that examined the relationship between hospital volume and short-term outcomes of cancer surgery have shown that the largest difference occurs with oesophageal resection [1] [2] [3] [4] . For example, Begg et al. [1] showed that the mortality rate after oesophagectomy was 17.3% in low-volume hospitals, but only 3.4% in high-volume hospitals.
However, fewer studies have investigated the relationship between hospital volume and long-term survival after oesophagectomy; moreover, their results have been contradictory [3] [4] [5] [6] [7] [8] [9] . For example, Birkmeyer et al. reported a 17% absolute difference in 5-year survival probabilities after oesophageal cancer resection between low-volume hospitals and high-volume hospitals [5] . In contrast, Thompson et al. [7] and Rouvelas et al. [8] did not find any relationship between hospital volume and 5-year survival probabilities. These discrepancies may be due to several limitations in these studies. For example, most population-based volume-outcome studies do not consider tumour stage, which is a major concern whenever long-term survival is examined. In addition, none of these types of studies performed subgroup analysis of preoperative oncological treatments. As a result, we conducted a population-based study in Taiwan to determine the impact of hospital volume on long-term survival after oesophagectomy, taking into consideration tumour stage and preoperative chemoradiation.
METHODS

Database and subjects
Patient data were obtained from the Taiwan Cancer Registry, which is a national population-based cancer registration database organized and funded by Health Promotion Administration, Ministry of Health and Welfare of the executive branch of the central government. Hospitals with more than 50-bed capacity that provide outpatient and hospitalized cancer care are recruited to participate in reporting all newly diagnosed malignant neoplasms to the registry. Specifically 
Categorization of hospital volume
The threshold for classifying low-and high-volume hospitals was based on the median (50th percentile) volume of 86 oesophagectomies at all hospitals between 2008 and 2011 (22 per year).
Outcome measures and analyses
The outcome measures for our study were short-term survival, which we defined as 30-day mortality after surgery, and long-term survival, which we defined as 1-and 3-year overall survival. Survival time was defined as the number of days between oesophagectomy and death or the end of the study on 31 December 2012, whichever occurred first.
Categorical and continuous variables were compared with the χ 2 test and Student's t-test, respectively. Survival curves were plotted using the Kaplan-Meier method and were compared with the log-rank test. Differences in survival estimates were calculated using the Cox proportional hazards regression model, stratified for hospital volume and adjusted for known prognostic factors. All statistical calculations were performed using statistics analysis system version 9.3 and statistical product and service solutions version 20. P-values <0.05 were considered statistically significant.
RESULTS
Patient characteristics
The clinical and pathological characteristics of patients who received oesophagectomies are summarized in Table 1 . Among the 2151 OSCC patients in this study who received oesophagectomies, 1301 (60.5%) did not receive any preoperative treatments, while 850 (39.5%) received preoperative chemoradiation. The average age of all patients was 55.2 years, and almost all patients were male (94.1%). R0 resection was achieved in 87.7% of all cases, and the 30-day mortality rate for all patients was 3.4%. Among 58 hospitals, 7 were classified as high volume, and 48.8% of all oesophagectomies were performed in these hospitals. In addition, 70.9% of all oesophagectomies were performed at 19 medical centres, 6 of which were high-volume hospitals. Only one non-centre hospital was classified as a high-volume hospital.
Patients who were treated at high-volume hospitals were more likely to be older than those treated at low-volume hospitals (55.7 vs 54.8 years, respectively, P = 0.033). In addition, patients who had surgery at low-volume hospitals were more likely to have cT1-2 stage and cN0 tumours than those who had surgery at highvolume hospitals (cT1-2 stage percentage: 36.3 vs 28.4%, P < 0.001; cN0 stage percentage: 40.0 vs 30.0%, P < 0.001).
Volume-outcome analysis
The survival rates for all patients, stratified by hospital type and volume, are summarized in Table 2 . Patients who were treated at high-volume hospitals had a significantly lower 30-day mortality rate than those who were treated at low-volume hospitals (2.1 vs 4.5%, respectively, P = 0.002). In addition, 1-and 3-year overall survival rates in high-volume hospitals (76.7 and 44.9%, respectively) were significantly higher than those in low-volume hospitals (70.0 and 40.2%, respectively, P = 0.002; Fig. 1A ). To decrease possible bias caused by unequal tumour stage distribution, survival curves were plotted after adjustment for age, sex, T stage, N stage, tumour location, grade and resection margin status. As shown in Fig. 1B , the survival was significantly better in high-volume hospitals (P < 0.001).
Subgroup analyses
We performed subgroup analyses of patients who were treated with or without preoperative chemoradiation. For patients who received preoperative chemoradiation, those who had surgery at low-volume hospitals were more likely to have cT1-2 stage and cN0 tumours than those who had surgery at high-volume hospitals (Table 1 . cT1-2 stage percentage: 17.4 vs 7.6%, P < 0.001; cN0 stage percentage: 18.6 vs 6.7%, P < 0.001). However, the distributions of ypT and ypN stages were similar between high-volume and low-volume hospitals (Table 1 ). Univariate analyses showed that statistically significant prognostic factors include cT stage, cN stage, pT stage, pN stage, tumour in the upper third of the oesophagus and resection margin status. The 1-and 3-year overall survival rates were 74.7 and 36.8%, respectively, in high-volume hospitals, compared with 73.5 and 42.6%, respectively, in lowvolume hospitals (P = 0.333, Fig. 1C , Table 2 ). Multivariate analyses confirmed that cN stage, pT stage, pN stage, tumour in the upper third of the oesophagus and resection margin status are statistically significant independent prognostic factors (Table 3) . However, hospital volume and type were not significant prognostic factors of survival.
For patients who did not receive preoperative chemoradiation, the distribution of clinical early T stage (cT1/2) was 43.2 and 47.7% in high-and low-volume hospitals, respectively (Table 1) . At pathological examination, those who had surgery at high-volume hospitals were more likely to have pT1 stage tumours than those (Table 4) . For example, the 1-and 3-year overall survival rates were 73.9 and 45.8%, respectively, in patients who received oesophagectomies at a medical centre, compared with 70.0 and 40.1%, respectively, at non-medical centre hospitals (P = 0.033, Table 2 ). Similarly, the 1-and 3-year overall survival rates were 78.1 and 50.0%, respectively, in patients who received oesophagectomies at high-volume hospitals, compared with 67.9 and 38.8%, respectively, at low-volume hospitals (P < 0.001, Fig. 1E , Table 2 ). Adjusted survival curves also showed that patients who had surgery at high-volume hospitals were associated with better outcome (P < 0.001, Fig. 1F ). In the multivariate analysis, hospital volume, cT stage, pT stage, pN stage and resection margin status remained statistically significant independent prognostic factors (Table 4) .
DISCUSSION
Since Luft et al. [10] published the first study on volume-outcome relationships in surgery in 1987, many subsequent studies have investigated the effect of hospital and surgeon volume on the outcomes of a variety of diseases. These studies have shown that high-volume hospitals tend to have better short-term postoperative outcomes, which can be measured as either postoperative mortality or complication rates, than low-volume hospitals [1] [2] [3] [4] . In addition, meta-analyses have demonstrated an inverse correlation between high hospital volume and short-term postoperative outcomes, including mortality and complication rates in oesophageal cancer surgery [11, 12] . Consequently, some authors have advocated centralizing low-volume, high-risk surgeries to improve survival and quality of care [13, 14] . For example, van de Poll-Franse et al. [13] reported that centralization of oesophagectomies improved 3-year survival rates from 32.0 to 45.1%. In contrast, the impact of hospital volume on long-term survival after oesophagectomy is less clear [3] [4] [5] [6] [7] [8] [9] . For example, several studies worldwide have demonstrated that high-volume hospitals have higher survival and lower mortality rates 1-5 years after surgery than low-volume hospitals [3] [4] [5] 9] . However, other studies have shown that these differences are not statistically significant [6] [7] [8] . Furthermore, meta-analyses and systematic reviews also have had contradictory results. For example, Brusselaers' meta-analysis of oesophagectomy studies showed that highvolume surgery results in better long-term survival than lowvolume surgery, whereas Rouvelas' review of studies that adjusted for tumour stage concluded that hospital volume does not have any influence on long-term survival after oesophagectomy [15, 16] . Owing to the combinatorial nature of meta-analyses and systematic reviews, these discrepancies may be due to the limitations and biases of individual studies. In this study, we compared the long-term survival rates of patients who received oesophagectomies at high-volume and low-volume hospitals and used subgroup analysis of preoperative treatments to identify independent prognostic factors after adjustment for tumour stage. Our finding that hospital volume is a significant prognostic factor of long-term survival supports the 'practice-makes-perfect' hypothesis, which states that hospitals that treat more patients have more experience, and therefore, such hospitals have higher survival rates than those that treat fewer patients [15] . However, we did not find any relationship between hospital volume and long-term survival among patients who received preoperative chemoradiation. Instead, we believe that tumour response to chemoradiation (i.e. ypT and ypN stages) determines the long-term survival in such patients, which is consistent with the result of a previous study showing that the response to neoadjuvant therapy is the major determinant of survival in patients with oesophageal cancer [17] . The ability of hospital volume to serve as a prognostic factor of long-term survival may be due to many underlying factors. Hospital volume is a complex variable that represents many aspects of a healthcare system and can serve as a surrogate variable for the quality of medical care, which includes the accuracy of diagnosis, appropriateness of treatments, expertise of surgeons and other hospital support staff, and the ability to deal with complications. All of these structural variables may contribute to the volume-outcome relationship for oesophagectomies. For example, studies have shown that patients who undergo oesophageal resection at hospitals at which patients are monitored daily by an intensive care unit (ICU) physician or at hospitals that have an ICU nurse-to-patient ratio of more than 1:2 have a lower incidence of postoperative complications [18] . Patients who are diagnosed at high-volume hospitals also are more likely to receive thorough investigations, which result in a greater proportion of tumours being staged accurately [19] .
In addition to hospital volume, other studies have investigated the effects of surgeon volume and hospital type on the outcome after oesophagectomies [20] [21] [22] [23] [24] . Some of these studies used surgeon volume as a proxy for technical expertise and quality of decisionmaking, but the validity of this substitution is not clear. For instance, Viklund et al. [20] reported that the risk of anastomotic leakage in oesophageal resections performed by low-volume surgeons was nearly eight times higher than in those performed by high-volume surgeons. In a population-based cohort study from Sweden, it was surgeon volume, not hospital volume, that independently influences the prognosis after oesophageal cancer surgery [21] . However, Rutegård et al. [23] showed that surgeon volume did not have any influence on the risk of complications after oesophageal cancer surgery. In addition, Jeganathan et al. [24] failed to demonstrate any influence of surgeon volume on operative mortality or long-term survival. Meta-analyses also have yielded conflicting results. For example, in a meta-analysis of the effect of both surgeon and hospital volume on outcome, Wouters et al. [11] found that the correlation between surgeon volume and postoperative mortality and survival was not significant. In contrast, Brusselaers et al. discovered that surgeon volume may be more important than hospital volume in long-term survival after oesophageal cancer surgery [16] .
Our finding that the association between hospital type and long-term survival after oesophageal cancer surgery is not significant in the multivariate analysis is consistent with some other studies, but the significance of the effect of hospital type on surgery outcome is uncertain. For example, some studies have found that prognoses are better in university hospitals than in other types of hospitals [25] . However, Virklund et al. [20] reported that hospital type did not influence the risk of complications. Similarly, Rodgers et al. showed that urban hospitals did not have better inpatient mortality than rural hospitals, and Bachmann et al. [19] found that the teaching status of hospitals did not have a significant effect on surgical outcome [22] . One of the strengths of our study is the population-based design and the relatively large number of patients. In Taiwan, the National Health Insurance (NHI) is a compulsory programme and was launched in 1995. According to the Taiwan Public Health Report 2011 (http://www.hpa.gov.tw/English/), the NHI coverage rate was 99.6%. In Taiwan, patients have free access to any healthcare system and provider they choose and hospitals have been divided into four grades: medical centres, regional hospitals, area hospitals and basic-level medical institutions. Hospital accreditation was organized by the Taiwan Joint Commission on Hospital Accreditation (TJCHA, http://www.tjcha.org.tw), which was established in 1999. The main business of the TJCHA thus includes hospital accreditation, teaching hospital accreditation, and certification and healthcare-related on-site inspection, hoping to help hospitals improve service and healthcare quality with accreditation.
In addition, we performed subgroup analyses of preoperative chemoradiation and adjusted for tumour stages, which has not been reported before. However, there are limitations of our study. First, the results may be limited by the fact that we did not consider surgeon volume, specific surgical procedures or postoperative treatments. Secondly, since the aim of our study was to evaluate whether there is a trend towards better or worse outcome associated with hospital volume status, instead of to obtain an optimum cut-off value, we did not calculate the optimum hospital volume threshold, but this is not likely to be a significant limitation because our threshold of 22 oesophagectomies per year is comparable with those used in other studies. For example, the Leapfrog group recommended that the threshold for high-volume hospitals should be 13-20 oesophagectomies per year [14] . Similarly, a meta-analysis by Metzger et al. [25] identified a threshold of 20 oesophagectomies per year. Finally, it should be noted that although we have shown that hospital volume is associated with better outcomes in general, it does not necessarily predict the performance of individual hospitals. Some high-volume hospitals may have relatively poor outcomes. Conversely, some low-volume hospitals may have excellent outcomes, but they may not be statistically significant because they do not treat many patients.
In conclusion, our results show that patients who receive oesophagectomies without preoperative chemoradiation at high-volume hospitals have a higher overall survival rate than those who are treated at low-volume hospitals. Furthermore, hospital volume remains an independent prognostic factor of surgery outcome after adjustment for tumour stage. However, we did not find any relationship between hospital volume and long-term outcome in patients who received preoperative chemoradiation. 
APPENDIX. CONFERENCE DISCUSSION
Dr B. Stiles (New York, NY, USA): That was a great paper and a great data set. It is curious, though, that your original hypothesis wasn't supported. You would have thought that the patients who got neoadjuvant therapy would represent the tougher operative candidates and you might see a bigger difference; at least that was my understanding when you were setting things up. There are not just low-and high-volume centres but probably a range in between, and I was wondering if you looked at the quartiles, or tried to break it up in any other way, to see if there was an effect from the really highperforming versus the really low-performing centres.
Dr Hsu: Maybe in the computer we just divided the patients into high and low volume hospitals. Maybe if we look into quartiles we will see different results. Volume is a continuous variable, and I saw in some papers that it's very dangerous to make a cutoff value; it is very dangerous to do so. So we just classify patients into high and low volume. We wanted to see whether there was a trend towards any survival difference.
Dr N. Altorki (New York, NY, USA): I have a question for you in the same area here. Let us say hypothetically that there is much more preoperative therapy going on in the high-volume hospital. Will you then lose the effect?
Dr Hsu: In my country, more and more thoracic surgeons start to follow the NCCN guidelines and more and more patients will receive neoadjuvant chemoradiation followed by surgery, but now there are still some older surgeons that prefer primary resection. But I think maybe several years in the future that our data will change.
Dr Altorki: So then the answer I presume is that we need to look more into where the bulk of the preoperative therapy is being done. Is it done in the highvolume hospitals or is it done in the low-volume hospitals?
Dr Hsu: Well, I think in Taiwan nowadays maybe a high-volume hospital will have a higher percentage of neoadjuvant chemoradiation.
Dr Altorki: I think you need to look at that number because that number may mislead the results.
The other question is, I noticed that the number of patients getting nonoperative therapy is almost three times higher than the number of patients getting an operation. What is going on in Taiwan?
Dr Hsu: Well, most of the patients who receive nonsurgical treatment are on medication and just don't want to have an operation.
Dr Altorki: Poor performance. Dr Hsu: Yes, sure.
